The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

被引：2
|
作者：
Dobler, Claudia C. [1 ]
机构：
[1] Mayo Clin, Evidence Based Practice Ctr, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA
来源：
BREATHE | 2018年 / 14卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1183/20734735.026418
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：333 / 335
页数：3
相关论文
共 50 条
  • [31] IMPACT Study: Cost-Effectiveness of Single-Inhaler Triple Therapy for the Treatment of COPD by Patients' Exacerbation History in Quebec
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Ismaila, A. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [32] A SYSTEMATIC REVIEW OF SINGLE-INHALER TRIPLE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Langham, S.
    Lewis, J.
    Pooley, N.
    Embleton, N.
    Langham, J.
    VALUE IN HEALTH, 2019, 22 : S873 - S873
  • [33] Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
    Long, Huanyu
    Xu, Hongxuan
    Janssens, Jean-Paul
    Guo, Yanfei
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [34] Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review
    Miranda, Juan Antonio Riesco
    Rubiob, Myriam Calle
    Perez, David Diaz
    Lopez-Campos, Jose Luis
    Carreroe, Juan Antonio Trigueros
    Cellif, Bartoloma
    ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (01): : 55 - 58
  • [35] Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
    Huanyu Long
    Hongxuan Xu
    Jean-Paul Janssens
    Yanfei Guo
    Respiratory Research, 22
  • [36] COST-EFFECTIVENESS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS TIOTROPIUM MONOTHERAPY IN PATIENTS WITH COPD IN THE UK
    Martin, A.
    Shah, D.
    Shukla, S.
    Kendall, R.
    Risebrough, N. A.
    Compton, C.
    Ismaila, A.
    VALUE IN HEALTH, 2022, 25 (01) : S40 - S40
  • [37] Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
    Sandeep Bansal
    Martin Anderson
    Antonio Anzueto
    Nicola Brown
    Chris Compton
    Thomas C. Corbridge
    David Erb
    Catherine Harvey
    Morrys C. Kaisermann
    Mitchell Kaye
    David A. Lipson
    Neil Martin
    Chang-Qing Zhu
    Alberto Papi
    npj Primary Care Respiratory Medicine, 31
  • [38] Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
    Bansal, Sandeep
    Anderson, Martin
    Anzueto, Antonio
    Brown, Nicola
    Compton, Chris
    Corbridge, Thomas C.
    Erb, David
    Harvey, Catherine
    Kaisermann, Morrys C.
    Kaye, Mitchell
    Lipson, David A.
    Martin, Neil
    Zhu, Chang-Qing
    Papi, Alberto
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2021, 31 (01)
  • [39] EFFECT OF ONCE-DAILY SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL TRIPLE THERAPY ON EXACERBATIONS COMPARED WITH BUDESONIDE/FORMOTEROL DUAL THERAPY IN PATIENTS WITH COPD AND NO HISTORY OF EXACERBATIONS: A POST HOC ANALYSIS OF THE FULFIL STUDY
    Panettieri, Reynold
    Bangalore, Mohan
    Camargo, Carlos
    Cheema, Tariq
    El Bayadi, Sherif
    Fiel, Stanley
    Jain, Renu
    Midwinter, Dawn
    Rabadi, Nashat
    Thomashow, Byron
    Lipson, David
    CHEST, 2021, 160 (04) : 1822A - 1825A
  • [40] Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety
    Suissa, Samy
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (03)
12345